FDA grants Natera MCED assay Breakthrough Device designation
Natera said its multi-cancer early detection (MCED) assay received Breakthrough Device Designation from the U.S. FDA.
Natera said its multi-cancer early detection (MCED) assay received Breakthrough Device Designation from the U.S. FDA.